Biodel Announces Publications Demonstrating Superior Metabolic Profile of VIAject Compared to the Rapid-acting - Biodel Inc.(Nasdaq: BIOD) announced today the publication of positive findings from studies demonstrating the superior metabolic profile of VIAject(TM) ultra rapid-acting insulin compared to the rapid-acting analog, Humalog(R),...
DIARY - Western European Corporate events from July 24, 2008 UPDATE ** For dates beyond Aug 05, click on [nWEUEQTY2] -------- ---- ----- ----------------------------------- ------------ ---------------- * DATE CO GMT COMPANY NAME EVENT RIC -------- ---- ----- ----------------------------------- ------------ ...
DIARY - Western European Corporate events from July 24, 2008 UPDATE 24/Jul BE Compagnie Maritime Belge NV Q2 <CMB.BR&gt; 24/Jul BE ICOS Vision Systems Corporation NV Q2 <IVIS.BR&gt; 24/Jul BE 0500 Mobistar SA H1 <MSTAR.BR&gt; 24/Jul BE Option International NV Q2 ...
Biodel Announces Publications Demonstrating Superior Metabolic Profile of VIAject(TM) Compared to the Rapid-ac Biodel Inc.(Nasdaq: BIOD) announced today the publication of positive findings from studies demonstrating the superior metabolic profile of VIAject(TM) ultra rapid-acting insulin compared to the rapid-acting analog, Humalog(R), and...
InteRNA Genomics Joins Applied Biosystems' SOLiD(TM) Software Community Program BILTHOVEN, The Netherlands, July 22 /PRNewswire/ -- InteRNA Genomics B.V.and Applied Biosystems Inc.
announce signing of a Software Community Commercial Membership Agreement regarding the exchange of InteRNA's information and software...
InteRNA Genomics Joins Applied Biosystems' SOLiD™ Software Community Program InteRNA Genomics B.V.and announce signing of a Software Community Commercial Membership Agreement regarding the exchange of InteRNA's information and software tools related to Applied Biosystems' SOLiD™ technology, InteRNA and...
InteRNA Genomics Joins Applied Biosystems' SOLiD„ Software Community Program InteRNA Genomics B.V.and Applied Biosystems Inc.announce signing of a Software Community Commercial Membership Agreement regarding the exchange of InteRNA's information and software tools related to Applied Biosystems' SOLiD technology,...
InteRNA Genomics Joins Applied Biosystems' SOLiD(TM) Software Community Program BILTHOVEN, The Netherlands The Applied Biosystems SOLiD(TM) System is a revolutionary genetic analysis platform that enables ultra -high-throughput (U-HTP) or massively parallel sequencing (MPS) of clonally amplified DNA fragments...
Applied Biosystems Adds New Members to Software Development Community to Advance Genomic Analysis Research - Applied Biosystems Inc.(NYSE:ABI) today announced the addition of new members to its Software Development Community by forming relationships with InteRNA Genomics B.V.
and Biotique Systems, Inc.
The commercial software solutions...
AgResearch gets Karen funds to improve accessibility to electron microscopes New Zealands AgResearch has been awarded more than $136,000 (NZ$180,000) to use the ultra -high-speed KAREN telecommunications network to enable scientists around the country to use its advanced electron microscopes remotely.The...
Joy of mum-to-be over hospital Sianna Martin with an ultra sound scan taken on June 20 A rejected mother-to-be is celebrating after being given a place at her hospital-of-choice thanks to the Times.Sianna Martin, of London Road, Wembley, applied to a number of...
Dussindale NHS walk-in centre to close :35 The walk-in health centre in Dussindale will close to make way for a new one in central Norwich.The decision to close the highly popular centre was made today despite a petition of 5,600 signatures, a heated public meeting and a...
Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia DUBLIN, Ireland Dr.Declan Doogan Thomas Lynch AMR101 is an ultra -pure ethyl ester of eicosapentaenoic acid (Ethyl-EPA).
Amarin has collected a substantial body of data on AMR101 to date.
Amarin has previously investigated AMR101...
Pressure BioSciences, Inc. Expands its PCT Consumables Product Line and PCT-Dependent Research Applications wi SOUTH EASTON, Mass.Nathan Lawrence About (PBI) is a publicly traded company focused on the development of a novel, enabling technology called Pressure Cycling Technology (PCT).
PCT uses cycles of hydrostatic pressure between ambient and...
Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia FDA Meeting to Discuss Development Plan Completed Successfully DUBLIN, Ireland, July 22 /PRNewswire-FirstCall/ -- Amarin Corporation plc today announced that the Company recently met with officials at the U.S.Food and Drug Administration ...
Pressure BioSciences, Inc. Expands its PCT Consumables Product Line and PCT-Dependent Research Applications wi SOUTH EASTON, Mass., July 22 /PRNewswire-FirstCall/ -- Pressure BioSciences, Inc.('PBI' or 'the Company') today announced an important expansion of its pressure cycling technology ('PCT') product line with the unveiling of a new PCT...
Researchers reveal secrets of the white horse [Date: 2008-07-22] For the first time, the genetic mutation resp For the first time, the genetic mutation responsible for giving white horses their attractive colour has been identified.An international team led by researchers at Uppsala University in Sweden has not only identified the mutation causing...
Pressure BioSciences, Inc. Expands its PCT Consumables Product Line and PCT-Dependent Research Applications wi SOUTH EASTON, Mass.Nathan Lawrence About Pressure BioSciences, Inc.
Pressure BioSciences, Inc.
(PBI) is a publicly traded company focused on the development of a novel, enabling technology called Pressure Cycling Technology (PCT).
Amarin Proceeding to Phase 3 with AMR101 for Hypertriglyceridemia FDA Meeting to Discuss Development Plan Completed Successfully DUBLIN, Ireland, July 22, 2008 Amarin Corporation plc (NASDAQ: AMRN) today announced that the Company recently met with officials at the U.S.Food and Drug Administration (FDA)...
Applied Biosystems Adds New Members to Software Development Community to Advance Genomic Analysis Research FOSTER CITY, Calif.--(Business Wire)-- Applied Biosystems Inc.
(NYSE:ABI) today announced the addition of new members to its Software Development Community by forming relationships with InteRNA Genomics B.V.
and Biotique Systems, Inc....
Applied Biosystems Adds New Members to Software Development Community to Advance Genomic Analysis Research - Applied Biosystems Inc.(NYSE:ABI) today announced the addition of new members to its Software Development Community by forming relationships with InteRNA Genomics B.V.
and Biotique Systems, Inc.
The commercial software solutions...
Applied Biosystems Adds New Members to Software Development Community to Advance Genomic Analysis Research InteRNA Genomics and Biotique Systems Offer SOLiD(TM) System Supported Software Solutions FOSTER CITY, Calif.--(BUSINESS WIRE)--Applied Biosystems Inc.(NYSE:ABI - News) today announced the addition of new members to its Software...
InteRNA Genomics Joins Applied Biosystems' SOLiD(TM) Software Community Program BILTHOVEN, The Netherlands, July 22 /PRNewswire/ -- InteRNA Genomics B.V.and Applied Biosystems Inc.
announce signing of a Software Community Commercial Membership Agreement regarding the exchange of InteRNA's information and software...
InteRNA Genomics Joins Applied Biosystems' SOLiD(TM) Software Community Program BILTHOVEN, The Netherlands, July 22 /PRNewswire/ -- InteRNA Genomics B.V.and Applied Biosystems Inc.
announce signing of a Software Community Commercial Membership Agreement regarding the exchange of InteRNA's information and software...
InteRNA Genomics Joins Applied Biosystems' SOLiD(TM) Software Community Program BILTHOVEN, The Netherlands, July 22 /PRNewswire/ -- InteRNA Genomics B.V.and Applied Biosystems Inc.
announce signing of a Software Community Commercial Membership Agreement regarding the exchange of InteRNA's information and software...
